The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
The lifestyle drugs market is currently worth a phenomenal $23bn; to boost its value, pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects, and is supported by forecasts to 2008. Seven key lifestyle drug sectors are covered
- Depression
- Oral contraception
- Sexual dysfunction
- Smoking cessation
- Obesity
- Alopecia
- Skin aging
Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.
Table of Contents
Download Table of Contents as a PDF
Other users found this report page using the following search terms: Depression contraception Sexual dysfunction Smoking Obesity Alopecia Skin aging lifestyle drugs
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.